What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis? ; volume:18 ; number:1 ; day:1 ; month:12 ; year:2016 ; pages:1-10 ; date:12.2016
Arthritis Research & Therapy ; 18, Heft 1 (1.12.2016), 1-10, 12.2016
- Creator
-
Humphreys, Jenny
- Contributor
-
Hyrich, Kimme
Symmons, Deborah
SpringerLink (Online service)
- DOI
-
10.1186/s13075-016-1176-x
- URN
-
urn:nbn:de:1111-201612208526
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Humphreys, Jenny
- Hyrich, Kimme
- Symmons, Deborah
- SpringerLink (Online service)
Other Objects (12)
Co-morbidities of vertiginous diseases
ARV regimen choice and co-morbidities
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Age-related co-morbidities in people living with HIV
0231. Growing old with HIV — dealing with co-morbidities
Pertussis in Individuals with Co-morbidities: A Systematic Review
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice
Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
PReS13-SPK-1129: Biologic therapies in SLE
Cardiovascular and musculoskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency
Co-morbidities of vertiginous diseases
ARV regimen choice and co-morbidities
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Age-related co-morbidities in people living with HIV
0231. Growing old with HIV — dealing with co-morbidities
Pertussis in Individuals with Co-morbidities: A Systematic Review
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice
Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
PReS13-SPK-1129: Biologic therapies in SLE
Cardiovascular and musculoskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency
Co-morbidities of vertiginous diseases
ARV regimen choice and co-morbidities
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
Age-related co-morbidities in people living with HIV
0231. Growing old with HIV — dealing with co-morbidities
Pertussis in Individuals with Co-morbidities: A Systematic Review
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
Psoriatic Arthritis: The Influence of Co-morbidities on Drug Choice
Data-driven identification of co-morbidities associated with rheumatoid arthritis in a large US health plan claims database
PReS13-SPK-1129: Biologic therapies in SLE